Cue Biopharma (CUE) Times Interest Earned (2017 - 2025)
Cue Biopharma (CUE) posted Times Interest Earned of $123.62 for Q4 2025, up 1053.84% sequentially from -$12.96 in Q3 2025, and up 473.66% YoY from $21.55 in Q4 2024.
Cue Biopharma (CUE) Times Interest Earned (2017 - 2025) Analysis & Trends
Cue Biopharma has reported Times Interest Earned for 9 years, with the latest figure at $123.62 in Q4 2025.
- Quarterly Times Interest Earned rose 473.66% year-over-year to $123.62 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $68.08 (down 87.53% YoY) and the FY2025 annual result came in at -$26.87, down 209.15% from the prior year.
- Times Interest Earned improved to $123.62 in Q4 2025 per CUE's latest filing, from -$12.96 in the prior quarter.
- Over five years, Times Interest Earned peaked at $123.62 in Q4 2025 and troughed at -$149.87 in Q1 2022.
- A 5-year average of -$22.31 and a median of -$10.45 in 2021 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned slumped 7458.34% in 2022, then jumped 473.66% in 2025.
- Over 5 years, Times Interest Earned stood at -$10.13 in 2021, then tumbled by 579.36% to -$68.82 in 2022, then soared by 130.09% to $20.71 in 2023, then gained by 4.07% to $21.55 in 2024, then surged by 473.66% to $123.62 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $123.62, -$12.96, and -$1.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 123.63 |
| Sep 30, 2025 | -12.96 |
| Jun 30, 2025 | -1.46 |
| Mar 31, 2025 | -3.15 |
| Dec 31, 2024 | 21.55 |
| Sep 30, 2024 | -10.78 |
| Jun 30, 2024 | -1.96 |
| Mar 31, 2024 | -2.06 |
| Dec 31, 2023 | 20.71 |
| Sep 30, 2023 | -16.11 |
| Jun 30, 2023 | -95.19 |
| Mar 31, 2023 | -40.55 |
| Dec 31, 2022 | -68.82 |
| Sep 30, 2022 | -88.96 |
| Jun 30, 2022 | -63.54 |
| Mar 31, 2022 | -149.87 |
| Sep 30, 2021 | -10.13 |
| Mar 31, 2021 | -1.98 |
| Sep 30, 2020 | -1.17 |
| Mar 31, 2020 | -11.07 |